Mckesson Corp (MCK): John H Hammergren , Chairman, President & CEO of Mckesson Corp sold 101,833 shares on May 10, 2016. The Insider selling transaction was reported by the company on May 10, 2016 to the Securities and Exchange Commission. The shares were sold at $170.71 per share for a total value of $1738438 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 26, 2016, John H Hammergren (Chairman, President & CEO) sold 101,833 shares at $176.82 per share price.On Mar 16, 2016, Nigel A Rees (SVP & Controller) sold 6,000 shares at $157.59 per share price.Also, On Feb 3, 2016, Susan R Salka (director) purchased 1,000 shares at $156.21 per share price.On Feb 2, 2016, Lori A. Schechter (EVP, GC & Chief Compl. Officer) sold 2,476 shares at $159.73 per share price.
Shares of McKesson Corporation (MCK) ended Friday, May 6, 2016 session in red amid volatile trading. The shares closed down -3.84 points or -2.22% at $168.86 with 20,85,852 shares getting traded. Post opening the session at $171.51, the shares hit an intraday low of $166.93 and an intraday high of $173.13 and the price vacillated in this range throughout the day. The company has a market cap of $37,997 M and the number of outstanding shares has been calculated to be 22,50,20,520 shares. The 52-week high of McKesson Corporation is $243.61 and the 52-week low is $148.29.
Company has been under the radar of several Street Analysts.McKesson Corporation is Downgraded by Avondale to Mkt Perform. Earlier the firm had a rating of Mkt Outperform on the company shares. The Rating was issued on May 5, 2016.McKesson Corporation is Downgraded by Standpoint Research to Hold. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Apr 26, 2016.McKesson Corporation is Initiated by Avondale to Mkt Outperform and the brokerage firm has set the Price Target at $203. The Rating was issued on Apr 19, 2016.McKesson Corporation is Initiated by Credit Suisse to Neutral. The Rating was issued on Mar 16, 2016.McKesson Corporation is Downgraded by Mizuho to Neutral and the brokerage firm has set the Price Target at $164. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Mar 1, 2016.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.